Literature DB >> 7755361

Cognitive scores in carriers of Huntington's disease gene compared to noncarriers.

T Foroud1, E Siemers, D Kleindorfer, D J Bill, M E Hodes, J A Norton, P M Conneally, J C Christian.   

Abstract

Huntington's disease (HD) is a progressive neurodegenerative disorder recently shown to be due to an excess number of CAG trinucleotide repeats in the 5' translated region of chromosome 4. One of the cardinal features of HD is cognitive decline. While mental deterioration is obvious later in the disease course, the time of its onset is difficult to determine precisely. A sample of at-risk individuals without signs or symptoms of HD by self-report was studied. The Wechsler Adult Intelligence Test--Revised and a neurological rating scale were administered. The genotypes of 394 individuals were then determined by polymerase chain reaction testing. On all portions of the WAIS-R test, the mean score of the HD gene carriers was lower than that of the noncarriers. Scores on two of the performance subtests, the digit symbol and the picture arrangement, were significantly different in the two groups, even after the scores from all gene carriers who were diagnosed as affected based on their neurological motor examination were removed. The scores for the gene carriers on the various subtests were negatively correlated with the number of CAG repeats in the expanded HD allele. Such a relationship was not seen with the normal alleles of the noncarriers. Taken together, our results suggest that a deficit in cognitive function is an early finding of HD and that in this patient population, the degree of cognitive deficit is proportional to the number of CAG repeats in the HD allele.

Entities:  

Mesh:

Year:  1995        PMID: 7755361     DOI: 10.1002/ana.410370516

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  28 in total

Review 1.  The importance of considering all attributes of memory in behavioral endophenotyping of mouse models of genetic disease.

Authors:  Michael R Hunsaker
Journal:  Behav Neurosci       Date:  2012-06       Impact factor: 1.912

2.  Visual scanning and cognitive performance in prediagnostic and early-stage Huntington's disease.

Authors:  Tanya Blekher; Marjorie R Weaver; Jeanine Marshall; Siu Hui; Jacqueline Gray Jackson; Julie C Stout; Xabier Beristain; Joanne Wojcieszek; Robert D Yee; Tatiana M Foroud
Journal:  Mov Disord       Date:  2009-03-15       Impact factor: 10.338

3.  Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation.

Authors:  J R Campodonico; A M Codori; J Brandt
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

Review 4.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Authors:  Ashok N Hegde; Sudarshan C Upadhya
Journal:  Biochim Biophys Acta       Date:  2010-08-03

5.  The effect of interference on temporal order memory in premanifest and manifest Huntington's disease.

Authors:  Diane R Nicoll; Eva Pirogovsky; Adrienne E Collazo; Savanna M Tierney; Jody Corey-Bloom; Paul E Gilbert
Journal:  J Huntingtons Dis       Date:  2013

6.  Neurotrophin receptor p75(NTR) mediates Huntington's disease-associated synaptic and memory dysfunction.

Authors:  Verónica Brito; Albert Giralt; Lilian Enriquez-Barreto; Mar Puigdellívol; Nuria Suelves; Alfonsa Zamora-Moratalla; Jesús J Ballesteros; Eduardo D Martín; Nuria Dominguez-Iturza; Miguel Morales; Jordi Alberch; Sílvia Ginés
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

7.  Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers.

Authors:  V Hahn-Barma; B Deweer; A Dürr; C Dodé; J Feingold; B Pillon; Y Agid; A Brice; B Dubois
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-02       Impact factor: 10.154

8.  Cognitive changes in patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study.

Authors:  Jurgen Lemiere; Marleen Decruyenaere; Gery Evers-Kiebooms; Erik Vandenbussche; Rene Dom
Journal:  J Neurol       Date:  2004-08       Impact factor: 4.849

Review 9.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

10.  Ten-year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.

Authors:  Andrea C Solomon; Julie C Stout; Marjorie Weaver; Sarah Queller; Allison Tomusk; Kathryn Burr Whitlock; Siu L Hui; Jeanine Marshall; Jacqueline Gray Jackson; Eric R Siemers; Xabier Beristain; Joanne Wojcieszek; Tatiana Foroud
Journal:  Mov Disord       Date:  2008-10-15       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.